DT-0111: a novel P2X3 receptor antagonist-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

DT-0111: a novel P2X3 receptor antagonist

Published:2023-03-22 Issue:3 Volume:19 Page:467-479
ISSN:1573-9538
Container-title:Purinergic Signalling
language:en
Short-container-title:Purinergic Signalling

Author:

Pelleg Amir,Sirtori Elena,Rolland Jean-Francois,Mahadevan Anu

Funder

Pennsylvania Department of Health

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Cellular and Molecular Neuroscience,Molecular Biology

Link

https://link.springer.com/content/pdf/10.1007/s11302-023-09930-5.pdf

Reference46 articles.

1. Nirody JA, Budin I, Rangamani P (2020) ATP synthase: Evolution, energetics, and membrane interactions. J Gen Physiol 152(11):e201912475

2. Corriden R, Insel PA (2010) Basal release of ATP: an autocrine-paracrine mechanism for cell regulation. Sci Signal 3(104):re1

3. Burnstock G (2014) Purinergic signalling: from discovery to current developments. Exp Physiol 99(1):16–34

4. Jacobson KA, Delicado EG, Gachet C, Kennedy C, von Kugelgen I, Li B, Miras-Portugal MT, Novak I, Schoneberg T, Perez-Sen R, Thor D, Wu B, Yang Z, Muller CE (2020) Update of P2Y receptor pharmacology: IUPHAR Review 27. Br J Pharmacol 177(11):2413–2433

5. Illes P, Muller CE, Jacobson KA, Grutter T, Nicke A, Fountain SJ, Kennedy C, Schmalzing G, Jarvis MF, Stojilkovic SS, King BF, Di Virgilio F (2021) Update of P2X receptor properties and their pharmacology: IUPHAR Review 30. Br J Pharmacol 178(3):489–514

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drugs Targeting Cough Receptors: New Therapeutic Options in Refractory or Unexplained Chronic Cough;Drugs;2024-06-21

2. Degranulation of human mast cells: modulation by P2 receptors’ agonists;Frontiers in Immunology;2023-10-05

3. Challenges and Future Trends in Atopic Dermatitis;International Journal of Molecular Sciences;2023-07-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3